Literature DB >> 17951258

Bone morphogenetic protein 2 opposes Shh-mediated proliferation in cerebellar granule cells through a TIEG-1-based regulation of Nmyc.

Rubén Alvarez-Rodríguez1, Mercedes Barzi, Jordi Berenguer, Sebastián Pons.   

Abstract

Nmyc is a potent regulator of cell cycle in cerebellar granular neuron precursors (CGNPs) and has been proposed to be the main effector of Shh (Sonic hedgehog) proliferative activity. Nmyc ectopic expression is sufficient to promote cell autonomous proliferation and can lead to tumorigenesis. Bone morphogenetic protein 2 (BMP2) antagonizes Shh proliferative effect by promoting cell cycle exit and differentiation in CGNPs. Here we report that BMP2 opposes Shh mitogenic activity by blocking Nmyc expression. We have identified TIEG-1 (KLF10) as the intermediary factor that blocks Nmyc expression through the occupancy of the Sp1 sites present in its promoter. We also demonstrate that TIEG-1 ectopic expression in CGNPs induces cell cycle arrest that can lead to apoptosis but fails to promote differentiation. Moreover, TIEG-1 synergizes with BMP2 activity to terminally differentiate CGNPs and independent differentiator signals such as dibutyryl cAMP and prevents apoptosis in TIEG-1 arrested cells. All together, these data strongly suggest that the BMP2 pathway triggers cell cycle exit and differentiation as two separated but coordinated processes, where TIEG-1 acts as a mediator of the cell cycle arrest.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17951258     DOI: 10.1074/jbc.M705414200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  BMP signaling modulates hedgehog-induced secondary heart field proliferation.

Authors:  Laura A Dyer; Frini A Makadia; Alexandria Scott; Kelly Pegram; Mary R Hutson; Margaret L Kirby
Journal:  Dev Biol       Date:  2010-10-14       Impact factor: 3.582

2.  The apical complex protein Pals1 is required to maintain cerebellar progenitor cells in a proliferative state.

Authors:  Jun Young Park; Lucinda J Hughes; Uk Yeol Moon; Raehee Park; Sang-Bae Kim; Khoi Tran; Ju-Seog Lee; Seo-Hee Cho; Seonhee Kim
Journal:  Development       Date:  2015-12-10       Impact factor: 6.868

3.  BMPs oppose Math1 in cerebellar development and in medulloblastoma.

Authors:  Matthew R Grimmer; William A Weiss
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

Review 4.  SHH pathway and cerebellar development.

Authors:  Catherine Vaillant; Denis Monard
Journal:  Cerebellum       Date:  2009-02-18       Impact factor: 3.847

Review 5.  Development and cancer of the cerebellum.

Authors:  Mary E Hatten; Martine F Roussel
Journal:  Trends Neurosci       Date:  2011-03       Impact factor: 13.837

6.  BMP-2 mediates PGE(2) -induced reduction of proliferation and osteogenic differentiation of human tendon stem cells.

Authors:  Jianying Zhang; James H-C Wang
Journal:  J Orthop Res       Date:  2011-06-17       Impact factor: 3.494

Review 7.  Functional role of KLF10 in multiple disease processes.

Authors:  Malayannan Subramaniam; John R Hawse; Nalini M Rajamannan; James N Ingle; Thomas C Spelsberg
Journal:  Biofactors       Date:  2010 Jan-Feb       Impact factor: 6.113

8.  TGFbeta inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts.

Authors:  M Subramaniam; J R Hawse; E S Bruinsma; S B Grygo; M Cicek; M J Oursler; T C Spelsberg
Journal:  Biochem Biophys Res Commun       Date:  2010-01-06       Impact factor: 3.575

9.  Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development.

Authors:  Haotian Zhao; Olivier Ayrault; Frederique Zindy; Jee-Hae Kim; Martine F Roussel
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

10.  MicroRNA 22 regulates cell cycle length in cerebellar granular neuron precursors.

Authors:  Jordi Berenguer; Antonio Herrera; Laura Vuolo; Blanca Torroba; Franc Llorens; Lauro Sumoy; Sebastian Pons
Journal:  Mol Cell Biol       Date:  2013-05-13       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.